Skip to main content

Complications of Cancer Chemotherapy

Proceedings of the Plenary Sessions of E.O.R.T.C., Paris, June 1973

  • Conference proceedings
  • © 1974

Overview

Part of the book series: Recent Results in Cancer Research (RECENTCANCER, volume 49)

This is a preview of subscription content, log in via an institution to check access.

Access this book

eBook USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

Licence this eBook for your library

Institutional subscriptions

Table of contents (20 papers)

Keywords

About this book

G. MATHE and R. K. OLDHAM'~ Institut de Cancerologie et d'Immunogem!tique, Hopital Paul Brousse, Villejuif Since the last war, cancer chemotherapy has been the object of very intensive and expensive research. Nevertheless, its development has been very slow, and its ultimate potential is today somewhat in doubt. In doubt because it does not cure any cancer patients except a) females carrying placental choriocarcinoma, a semi-allogenic tumor, in which case, cure may be in­ fluenced by immune rejection, and b) children suffering from Burkitt's tumor, where the probable reason for the cure is that all the neoplastic cells are in the cycle, which is a unique condition among all the human tumor varieties. Whether the long term survivors in acute leukemia, lymphomas, certain sarcomas and certain testicular tumors are "cures" will require longer follow-up. The idea that chemotherapy does not cure most cancer patients because all their neoplastic cells are not in cycle has led to the use of drug combinations. Whatever they are, "cocktail combinations" which are made up of drugs given according to any timing, or scientific combinations, based on pharmacodynamics, pharmaco­ kinetics or cell kinetics data, are more toxic than single drugs, and are all the more toxic as the number of drugs in the combination is increased.

Editors and Affiliations

  • Institut de Cancérologie et d’Immunogénétique, Hôpital Paul-Brousse, Villejuif, France

    Georges Mathé

  • Cellular and Tumor Immunology Section Department of Health, Education and Welfare, N.I.H., Bethesda, USA

    Robert K. Oldham

Bibliographic Information

  • Book Title: Complications of Cancer Chemotherapy

  • Book Subtitle: Proceedings of the Plenary Sessions of E.O.R.T.C., Paris, June 1973

  • Editors: Georges Mathé, Robert K. Oldham

  • Series Title: Recent Results in Cancer Research

  • DOI: https://doi.org/10.1007/978-3-642-80848-7

  • Publisher: Springer Berlin, Heidelberg

  • eBook Packages: Springer Book Archive

  • Copyright Information: Springer-Verlag Berlin · Heidelberg 1974

  • Softcover ISBN: 978-3-642-80850-0Published: 09 January 2012

  • eBook ISBN: 978-3-642-80848-7Published: 06 December 2012

  • Series ISSN: 0080-0015

  • Series E-ISSN: 2197-6767

  • Edition Number: 1

  • Number of Pages: VI, 142

  • Number of Illustrations: 4 b/w illustrations

  • Topics: Rehabilitation, Cancer Research

Publish with us